Eli Lilly’s Animal Division Reports 20% Q4 Increase



Published:

Eli Lilly and Co.’s animal health division reported revenue of $424.3 million for its fourth quarter ended Dec. 31, up 20 percent compared to revenue of $353.1 million in the year-ago period.

U.S. sales grew 25 percent to $234.5 million, due to increased demand, according to the Indianapolis-based company. Sales outside the U.S. increased 15 percent to $189.8 million, driven by increased demand and the impact of a recent acquisition, the company reported.

Year to date, the division reported revenue of $1.4 billion, compared to revenue of $1.2 percent in the year-ago period.

Animal health sales in the U.S. and outside the U.S. increased 15 percent to $775.1 million and $616.3 million, respectively, driven primarily by increased demand, according to the company.

Overall, Eli Lilly and Co. reported net income of $1.2 billion on revenue of $6.2 billion for its fourth quarter, compared to net income of $915.4 million on revenue of $5.9 billion in the year-ago period.

Year to date, the company reported net income of $5.1 billion on revenue of $23.1 billion, compared to net income of $4.3 billion on revenue of $23.8 billion in the year-ago period.

<Home>

Archive »Read More

Merck Awards $5,000 Student Scholarships

Merck Animal Health recognizes 15 veterinary students interested in bovine medicine.

Jaguar Animal Health Has Taste for New Drugs

Gastrointestinal drug developer Jaguar Animal Health files its eighth Investigational New Animal Drug application.

OSU Vet College Raises Funds for Cancer Research

The Ohio State University College of Veterinary Medicine is once again participating in Pelotonia, an annual fundraiser for cancer research.

Add your comment:

Events


Show More...